Cellular signallingOct 20, 2025

IL-11 may worsen cisplatin kidney damage by increasing cell death through disrupted cell cleanup in kidney tubule cells

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Jan 19, 2026

Abstract

IL-11 knockdown significantly improved renal function in a mouse model of cisplatin-induced acute kidney injury.

Cisplatin-induced acute kidney injury is associated with increased levels of interleukin-11, which drives tubular injury.
Knockdown of IL-11 reduced tubular damage and improved markers of renal function, including serum creatinine and blood urea nitrogen.
IL-11 activation leads to mitochondrial fragmentation and a decrease in autophagic activity due to suppressed lysosomal maturation.
Inhibition of the ERK1/2 pathway and overexpression of TFEB can restore lysosomal function and reduce cell apoptosis and senescence.
In vitro studies show that recombinant human IL-11 induces similar pathways in renal cells, linking IL-11 to kidney cell injury.

Simplified

Cisplatin-induced acute kidney injury (Cis-AKI) lacks targeted therapies. Here we identify interleukin-11 (IL-11) as a key driver of tubular injury that couples mitochondrial dynamics to autophagic flux in renal tubular epithelial cells. In a mouse Cis-AKI model, IL-11 knockdown ameliorated tubular damage and significantly improved renal function (serum creatinine, blood urea nitrogen), with concordant restoration of AQP1 and reduction of KIM-1/NGAL, indicating robust protection at the tissue and functional levels. Mechanistically, IL-11 activated ERK1/2, increased Drp1 phosphorylation and mitochondrial fission, and suppressed TFEB activity to impair lysosomal maturation and autophagic flux; ERK inhibition (SCH772984) and TFEB overexpression rescued TFEB activity, lysosomal markers, and autophagic completion, and reduced apoptosis/senscence. Tissue-level readouts (IHC for p-Drp1 and p62; immunoblots for LC3-I/II and p62) and TEM ultrastructure corroborated these pathways in vivo, linking mitochondrial fragmentation and autophagic blockade to IL-11-dependent injury. In HK-2 cells, recombinant human IL-11 (50 ng/mL) reproduced ERK-Drp1/TFEB pathway activation and phenotypes, and loss-of-function of IL-11 attenuated cisplatin-induced apoptosis and senescence. Collectively, these data define an ERK1/2-Drp1/TFEB axis by which IL-11 exacerbates Cis-AKI through mitochondrial dysfunction and autophagic flux disruption, culminating in apoptosis and cellular senescence. Targeting IL-11 or restoring TFEB activity emerges as a mechanism-based strategy to mitigate cisplatin nephrotoxicity.

Full Text

Full text is available at the source.

View Full Text ↗

Funding

Competing interests

Declaration of competing interest The authors declare that there are no competing interests associated with the manuscript.

PubMed

IL-11 may worsen cisplatin kidney damage by increasing cell death through disrupted cell cleanup in kidney tubule cells

Abstract

Full Text

Funding

Competing interests

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the longevity & aging brief